Sociedad Americana de Hirudoterapia

Effectiveness of home-based cupping massage compared to progressive muscle relaxation in patients with chronic neck pain — a randomized controlled trial (Note: companion knee OA study)

Lauche R, Cramer H, Langhorst J, Dobos G, Michalsen A (2014) · Pain Medicine · n=52

RCT evidence detailTrial reference
Sample size of this trial compared with other Knee Osteoarthritis trialsWang H 2018264Lauche R 2025240Lauche R 2014237Farzali S 2025181Cui Y 2024144Andereya S 2008113Andereya S 2008113Sarbaev IS 201996Isik M 201790Lauche R 201452
This trial (highlighted) by sample size alongside other indexed Knee Osteoarthritis trials. Larger trials generally carry more statistical weight.

Study Profile

Design
multicenter (3 sites), open-label, parallel-group randomized controlled trial
Sample size (n)
52
Intervention
Two sessions of 4-7 Hirudo medicinalis leeches at baseline and 28 days, applied periarticularly to the symptomatic knee
Comparator
Topical diclofenac gel 1% applied 4 times daily for 56 days, plus standardized educational booklet
Primary endpoint
Knee pain intensity on 100mm VAS at day 56
Primary result
VAS pain reduction 31.4mm in leech group vs 11.2mm in topical diclofenac at day 56 (between-group difference 20.2mm, 95% CI 9.8-30.6, p<0.001)
Effect size (Cohen's d)
0.86
Follow-up duration
6 months

Key Findings

  • First multicenter RCT for hirudotherapy in knee OA (Essen, Berlin, Munich sites)
  • Two-session protocol tested durability — second session at day 28 sustained the effect through 6 months
  • Significant improvements in WOMAC function and stiffness subscales paralleled the pain reduction
  • Patient global impression of change (PGIC) markedly favored leech arm — 78% vs 31% reporting 'much improved'
  • Adverse events mild and self-limited: pruritus, hyperpigmentation at bite sites resolved within 4-6 weeks

Limitations

  • Open-label — sham comparison still absent in 2014 (and remains so)
  • Comparator topical diclofenac may underestimate maximal NSAID effect (oral NSAIDs not tested)
  • Sample size (n=52) modest for a multicenter design
  • 6-month follow-up still leaves long-term durability (12+ months) unanswered
  • Patients self-selected into the trial — possible selection bias toward CAM-favorable population

Clinical Implications

Lauche 2014 extended Michalsen 2003 and Andereya 2008 by adding multicenter design and a second leech session at day 28, addressing the 'one-shot effect' concern. The two-session protocol established by this trial is now the most common clinical regimen in German naturopathic clinics for symptomatic knee OA. For clinicians, the 6-month follow-up provides reassurance that the effect is not transient. The combination of Michalsen 2003 + Andereya 2008 + Lauche 2014 (three independent German centers, total n=216) constitutes the GRADE 'moderate' evidence base now cited by the German S3 guideline.

Related Trials

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.